Targeting tyrosine phosphatases: time to end the stigma

SM Stanford, N Bottini - Trends in Pharmacological Sciences, 2017 - cell.com
Protein tyrosine phosphatases (PTPs) are a family of enzymes essential for numerous
cellular processes, and several PTPs have been validated as therapeutic targets for human …

The implication of STEP in synaptic plasticity and cognitive impairments in Alzheimer's disease and other neurological disorders

YAR Mahaman, F Huang, KS Embaye… - Frontiers in Cell and …, 2021 - frontiersin.org
STriatal-Enriched protein tyrosine Phosphatase (STEP) is a tyrosine phosphatase that has
been implicated in Alzheimer's disease (AD), the most common form of dementia, and many …

Fbxo45‐mediated NP‐STEP46 degradation via K6‐linked ubiquitination sustains ERK activity in lung cancer

Q Wang, C Xu, R Cai, W An, H Yuan… - Molecular Oncology, 2022 - Wiley Online Library
Lung cancer is one of the most threatening malignant tumors to human health. Epidermal
growth factor receptor (EGFR)‐targeted therapy is a common and essential means for the …

BDNF increases synaptic NMDA receptor abundance by enhancing the local translation of Pyk2 in cultured hippocampal neurons

P Afonso, P De Luca, RS Carvalho, L Cortes… - Science …, 2019 - science.org
The effects of brain-derived neurotrophic factor (BDNF) in long-term synaptic potentiation
(LTP) are thought to underlie learning and memory formation and are partly mediated by …

Striatal-enriched tyrosine protein phosphatase (STEP) in the mechanisms of depressive disorders

E Kulikova, A Kulikov - Current Protein and Peptide Science, 2017 - ingentaconnect.com
Striatal-enriched tyrosine protein phosphatase (STEP) is expressed mainly in the brain. Its
dysregulation is associated with Alzheimer's and Huntington's diseases, schizophrenia …

[HTML][HTML] Molecular underpinnings of neurodegenerative disorders: striatal-enriched protein tyrosine phosphatase signaling and synaptic plasticity

PJ Lombroso, M Ogren, P Kurup, AC Nairn - F1000Research, 2016 - ncbi.nlm.nih.gov
This commentary focuses on potential molecular mechanisms related to the dysfunctional
synaptic plasticity that is associated with neurodegenerative disorders such as Alzheimer's …

Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP61

J Xu, P Kurup, AC Nairn, PJ Lombroso - Molecular neurobiology, 2018 - Springer
NMDA receptor signaling is critical for the development of synaptic plasticity, learning, and
memory, and dysregulation of NMDAR signaling is implicated in a number of neurological …

Benzopentathiepine derivative, 8-(trifluoromethyl)-1, 2, 3, 4, 5-benzopentathiepin-6-amine hydrochloride (TC-2153), as a promising antidepressant of new generation

E A. Kulikova, K P. Volcho… - Letters in Drug …, 2017 - benthamdirect.com
Background: Depressive disorders are among four leading causes of burden among the
most disabling medical illnesses and antidepressant drugs (AD) occupying leading …

Proteolytic Degradation of Hippocampal STEP61 in LTP and Learning

A Saavedra, JJ Ballesteros, S Tyebji… - Molecular …, 2019 - Springer
Striatal-enriched protein tyrosine phosphatase (STEP) modulates key signaling molecules
involved in synaptic plasticity and neuronal function. It is postulated that STEP opposes the …

Age-related changes in STriatal-Enriched protein tyrosine Phosphatase levels: Regulation by BDNF

S Cases, A Saavedra, S Tyebji, A Giralt… - Molecular and Cellular …, 2018 - Elsevier
Recent results indicate that STriatal-Enriched protein tyrosine Phosphatase (STEP) levels
are regulated by brain-derived neurotrophic factor (BDNF), whose expression changes …